Calcium Hydroxide Intracanal medication
Preclinical
Calcium Hydroxide Intracanal medication is one of 47 therapeutic programs targeting Post Operative Pain. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
46
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
61 competitors in Post Operative Pain
#DrugCompanyPhaseTrials
1Marcaine
IInnocoll
Approved
Advil
KKenvue Brands
Approved
Duragesic
CCephalon
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Ketalar
AAultman Health Foundation
Approved
Oxycontin
PProtega
Approved
Epsom Salt
FFresenius Kabi USA, LLC
Approved
Tylenol
KKenvue Brands
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
EXPAREL
Pacira Pharmaceuticals, IncApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]
- Company
- AAnkara University